Tele-Health Learning for Intestinal Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a tele-health program called LIFT-ECHO (Learn Intestinal Failure Tele-ECHO Program) can help doctors enhance treatment and quality of life for patients with chronic intestinal failure. LIFT-ECHO includes virtual sessions where doctors learn from experts about managing this condition, which often requires patients to receive nutrition through an IV at home. Patients who have been on home IV nutrition for more than six months, without cancer or HIV, and their doctors, are well-suited for this study. The trial will monitor whether these learning sessions lead to better health outcomes for the patients. As an unphased trial, this study provides a unique opportunity for patients to contribute to innovative healthcare solutions and potentially improve their own treatment outcomes.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on evaluating a tele-health program rather than changing your medication regimen.
What prior data suggests that the LIFT-ECHO program is safe for improving clinical outcomes in patients with intestinal failure?
Research has shown that the Learn Intestinal Failure Tele-ECHO (LIFT-ECHO) program is based on the successful ECHO model. This program aids doctors in managing chronic intestinal failure, a condition where the body can't absorb nutrients properly. Importantly, LIFT-ECHO doesn't require new medications or medical procedures. It is a tele-health program focused on education and improving care through discussions and presentations.
Regarding safety, patients face no direct health risks since they aren't receiving new treatments or drugs. The program aims to help doctors provide better care, potentially leading to improved health over time. As an educational initiative designed to enhance knowledge and skills in managing intestinal failure, no negative effects have been reported.12345Why are researchers excited about this trial?
Researchers are excited about the Tele-Health Learning for Intestinal Failure trial because it explores a novel approach to managing chronic intestinal failure through tele-mentoring. Unlike traditional treatment methods that heavily rely on in-person physician visits and direct clinical interventions, this trial investigates the potential of the LIFT-ECHO program to enhance physician knowledge and patient outcomes via virtual means. By providing continuous education and support to physicians remotely, the trial aims to improve the management of patients requiring parenteral nutrition, potentially leading to better clinical outcomes and quality of life for patients without frequent hospital visits.
What evidence suggests that the LIFT-ECHO program is effective for improving clinical outcomes and patient quality of life in intestinal failure?
Research has shown that the LIFT-ECHO program can improve care for patients with chronic intestinal failure. In this trial, some physicians will not initially receive Tele-Mentoring, while others will join the LIFT-ECHO program after a baseline period. Past studies have demonstrated active participation from many doctors across various regions, indicating that more doctors are learning to better support their patients with this condition. The program educates doctors through online sessions, effectively sharing important knowledge. By enhancing doctors' understanding, patients may experience better health and a higher quality of life.13678
Who Is on the Research Team?
Kishore Iyer, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Are You a Good Fit for This Trial?
This trial is for patients with Intestinal Failure-associated Liver Disease and Intestinal Failure. Clinicians who are non-specialists in CIF but manage these patients can also participate to improve their knowledge through the LIFT-ECHO program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Control
Patients are followed for a baseline period of 6 months to assess clinical outcomes and patient-reported quality of life
Intervention
Physicians participate in the LIFT-ECHO program, consisting of 8 one-hour sessions over 2-4 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Learn Intestinal Failure Tele-ECHO Program
Trial Overview
The study tests the effectiveness of the LIFT-ECHO tele-health learning program, which aims to enhance clinicians' understanding of intestinal failure via case discussions and expert lectures. The impact on patient quality of life and clinical outcomes will be measured.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Dyads consisting of a prescribing physician and one or more of their patients receiving parenteral nutrition (PN). Physicians in this arm will participate in the LIFT-ECHO program. After patients complete a baseline period of 6 months (Control period), their physician receives the intervention (LIFT-ECHO).
Dyads consisting of a prescribing physician and one or more of their patients receiving parenteral nutrition (PN). Physicians in this arm will be invited to participate but would not yet have received the Tele-Mentoring (LIFT-ECHO) focused on the management of chronic intestinal failure. Patients of these physicians will be followed for a baseline period of 6 months (Control period) to assess evolution in clinical outcomes and patient-reported quality of life.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
London School of Economics and Political Science
Collaborator
University of Utah
Collaborator
Rhode Island Hospital
Collaborator
The New York Academy of Medicine
Collaborator
Citations
Study Details | NCT07094308 | The LIFT-ECHO Last Mile ...
... intestinal failure (CIF) on parenteral nutrition (PN). The intervention consists of eight 60-90-minute sessions delivered over 2-4 months ...
2.
researchgate.net
researchgate.net/publication/349039880_Disseminating_Knowledge_in_Intestinal_Failure_-_Initial_Report_of_the_Learn_Intestinal_Failure_Tele-ECHO_LIFT-ECHO_ProjectInitial Report of the Learn Intestinal Failure Tele-ECHO (LIFT ...
Results: The LIFT-ECHO program has achieved significant geographic reach and clinician engagement. The program has reached close to two-thirds of the states in ...
3.
digital.ahrq.gov
digital.ahrq.gov/ahrq-funded-projects/patient-intestinal-failure-echo-project-pif-echoPatient Intestinal Failure-ECHO Project (PIF-ECHO)
Chronic intestinal failure is a severe condition that prevents patients from absorbing essential nutrients and fluids, requiring long-term parenteral nutrition ...
Tele-Health Learning for Intestinal Failure
Learn Intestinal Failure Tele-ECHO Program. Trial Overview The study tests the effectiveness of the LIFT-ECHO tele-health learning program, which aims to ...
ECHO Model for Enhancing Chronic Intestinal Failure Care
Study AimThis study, ECHO Model for Enhancing Chronic Intestinal Failure Care, aims to improve health services for individuals on home parenteral nutrition.
Safety and quality of parenteral nutrition - PubMed Central
Based on the ECHO model, the Learn Intestinal Failure Tele-ECHO (LIFT-ECHO) project was launched in 2019 to support the treatment and management of patients ...
Intestinal Failure | Vol 6, Suppl 1, 2025
... Learn Intestinal Failure Tele-ECHO ... Cost of home parenteral nutrition and intestinal transplantation for children with chronic intestinal failure in Singapore.
Educational Video for Intestinal Failure
The goal of this clinical trial is to develop an educational video addressing the aseptic techniques to safely handle central catheters for administrating ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.